if anyone want is interested in our largest share holder and where NYR as a drug molecule came from read up on NOX and the continual success of their portfolio. NYR has an important September ahead
- Forums
- ASX - By Stock
- NYR
- Ann: Brain Injury Program GLP Studies Further Update
NYR
nyrada inc.
Add to My Watchlist
4.00%
!
24.0¢

Ann: Brain Injury Program GLP Studies Further Update, page-38
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $50.62M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 23.5¢ | $68.17K | 285.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27265 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 27265 | 0.240 |
3 | 119668 | 0.235 |
5 | 187086 | 0.230 |
2 | 6925 | 0.225 |
3 | 157420 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 5000 | 1 |
0.250 | 134832 | 4 |
0.255 | 125000 | 2 |
0.260 | 204498 | 3 |
0.265 | 178500 | 4 |
Last trade - 11.16am 27/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online